Kythera, Bayer tout PhIII results on ATX-101; Mouse study indicates potential of stroke treatment;

 @FierceBiotech: The Biggest R&D Spenders In Biopharma. Special Report | Follow @FierceBiotech

 @JohnCFierce: AVI's retake on IIb DMD data looks to me like a second attempt at a good first impression. Release | Follow @JohnCFierce

 @RyanMFierce: Perakslis: FDA plans to open up some of the FDA's liver tox data on >2000 drugs to outside parties. A good example of data sharing. | Follow @RyanMFierce

> Kythera and Bayer announced the "successful completion of two pivotal European Phase III clinical trials with ATX-101, an injectable drug for the reduction of unwanted fat under the chin. Release

> Repligen ($RGEN) says it successfully wrapped a Phase I study to evaluate the pharmacokinetic and safety profile of RG3039, a candidate for spinal muscular atrophy. Release

> RainTree Oncology, which provides oral oncology drug acquisition and management services, has closed an $11.1 million round. Robert M. Bass is the lead investor. Release

Pharma News

 @FiercePharma: Zyprexa sales fell off a (patent) cliff, but Lilly still beat analyst forecasts for Q1--Reuters. News | Follow @FiercePharma

> GSK scrapes up 2% sales growth despite politics, generics. Article

> Spurned GSK chief: We're the 'compelling owner' for HGS. Story

Medical Devices News

@FierceMedDev: BioMérieux Q1 2012 sales soar, propelled by China, India. Story | Follow @FierceMedDev

> Medtronic bets IT enhancements will boost revenue. Item

> Expanded use for Edwards' Sapien heart valve faces FDA delay. More

> Analytical instruments, specialty diagnostics drive Thermo Fisher Q1 sales. Article

Drug Delivery News

 @DamianFierce: Tamarisk plans to "turn the industry upside down" with oral insulin platform. News | Follow @DamianFierce

> 'Chemo bomb' nanotechnology effective in halting tumors. Story

> SkyePharma's inhaler takes step toward EMA approval. Article

> Scottish scientists take a page from sci-fi with sonic screwdriver. More

> Australia jumps into life sciences fray with R&D tax credit. Piece

Biomarkers News

> Autism Awareness Month and autism biomarkers. Commentary

> Novo Nordisk, Oxford University seeking inflammation markers. More

> Urine biomarker test for autism on the horizon? Story

> 'Landmark' study splits breast cancer into 10 types. News

And Finally… A team of investigators says that it has gathered promising animal data in a mouse study of a new drug to treat stroke damage. Story